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Geology, Queensborough Community College, Bayside, New YorkABSTRACT Cardiomyocytes have a complex Ca2þ behavior and changes in this behavior may underlie certain disease states.
Intracellular Ca2þ activity can be regulated by the phospholipase Cb–Gaq pathway localized on the plasma membrane. The
plasma membranes of cardiomycoytes are rich in caveolae domains organized by caveolin proteins. Caveolae may indirectly
affect cell signals by entrapping and localizing specific proteins. Recently, we found that caveolin may specifically interact
with activated Gaq, which could affect Ca
2þ signals. Here, using fluorescence imaging and correlation techniques we show
that Gaq-Gbg subunits localize to caveolae in adult ventricular canine cardiomyoctyes. Carbachol stimulation releases Gbg
subunits from caveolae with a concurrent stabilization of activated Gaq by caveolin-3 (Cav3). These cells show oscillating
Ca2þwaves that are not seen in neonatal cells that do not contain Cav3. Microinjection of a peptide that disrupts Cav3-Gaq asso-
ciation, but not a control peptide, extinguishes the waves. Furthermore, these waves are unchanged with rynaodine treatment,
but not seen with treatment of a phospholipase C inhibitor, implying that Cav3-Gaq is responsible for this Ca
2þ activity. Taken
together, these studies show that caveolae play a direct and active role in regulating basal Ca2þ activity in cardiomyocytes.INTRODUCTIONSmall scale and local release of Ca2þ in cardiomyocytes,
such as sparks and puffs, underlie the activity of larger scale
Ca2þ signals (see (1,2)). Sparks and puffs are disrupted in
diverse diseases such as diabetes and muscular dystrophy
(see (1)). To date, the major focus of this Ca2þ activity
has been the receptors that allow for intracellular Ca2þ
release in the sarcoplasmic reticulum such as inositol
1,4,5, trisphophate (IP3) receptors and intracellular Ca
2þ
channels (IP3R) that open upon binding of IP3 (3,4). IP3R
release of Ca2þ is propagated by ryanodine receptors
(RyRs) that open upon Ca2þ binding. RyRs are the major
source of Ca2þ -induced Ca2þ release in cardiac muscle
cells (5). Release of Ca2þ ions due to RyRs are termed
sparks, whereas those caused by IP3R are called puffs. To
date, the factors that cause the initiation, propagation, and
termination of Ca2þ sparks/puffs have not yet been fully
characterized.
In this study, we focus on the control of Ca2þ puffs in car-
diomyocytes resulting from IP3R activity. IP3 is generated
through phospholipase C (PLC)—catalyzed hydrolysis of
the signaling lipid, phosphatidylinositol 4,5 bisphosphate
(PIP2). Of the major PLCs in cardiac tissue, the PLCb
family is activated by G-proteins that are coupled to
hormonal and neural activity. All four known PLCb isoen-
zymes are activated by the Gaq family of heterotrimeric
G-proteins (6,7). Gaq is coupled to G-protein-coupled
receptors (GPCRs) that specifically bind ligands such asSubmitted December 9, 2010, and accepted for publication February 7,
2011.
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tensin (8,9). Additionally, two PLCb isotypes, PLCb2 and
b3, are activated by Gbg subunits that can potentially be
released from all Ga families.
Although ligand binding to its specific GPCR produces
rapid activation of PLCb, signal termination is generally
thought to be caused by receptor clustering and internaliza-
tion, Gaq deactivation and/or depletion of PIP2. We have
recently found a link between the time scale of signals
generated through PLCb/Gaq activation and the protein cav-
eolin-1 (Cav1). Cav1 is the main structural component of
membrane protein domains called caveolae. In many muscle
cells such as cardiomyocytes, Cav3 is the major caveolin
isoform (for reviews see (10–13)). Although the precise
function of caveolae is unclear, these domains have been
shown to play roles in vesicle trafficking and endocytosis.
Additionally, caveolae have been postulated to act as scaf-
folds that organize signaling proteins on the plasma
membrane surface.
There is evidence that many types of GPCRs and
G-protein subunits localize to caveolae domains (14).
Cell fractionation and immunofluorescence studies suggest
that Gaq localizes to Cav1 domains (15,16). In vitro, we
and others have detected a strong interaction between acti-
vated Gaq and Cav1 that is diminished when Gaq becomes
deactivated (16,17). In contrast, Gbg does not specifically
bind to Cav1. Thus, the loss in affinity between Gaq and
Gbg that occurs upon activation, coupled with the increase
in interaction between activated Gaq and Cav1, may
promote diffusion of Gbg subunits out of caveolae
domains and prolong the recombination time of the G het-
erotrimer (16). In Fisher rat thyroid (FRT) cells stably
transfected with Cav1, we have observed a prolongeddoi: 10.1016/j.bpj.2011.02.013
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agonist, carbachol, but only when PLCb was overex-
pressed. We postulated that this prolonged response was
due to a combination of stabilization of activated Gaq by
Cav1, and the release of Gbg from caveolae domains,
which allows for sustained PLCb activation and results in
a longer Ca2þ signal.
There is strong evidence that caveolae play a key role in
the heart. Lisanti and co-workers found that Cav3 null mice
develop progressive cardiomyopathy that is in some way
connected to the ERK1/2 pathway (18). It is possible that
the connection between the hyperactivation of cardiomyo-
cytes in Cav3 null mice is linked ERK1/2 via the Gaq/
Gbg pathway. In this study, we explicitly show that Gbg
subunits are released from caveolae domains and that caveo-
lae stabilize the activated state of Gaq. Of importance, the
interaction between Cav3 and Gaq regulates Ca
2þ puffs in
adult cardiomyocytes. These studies connect caveolae regu-
lation of Ca2þ signals with G-protein activity.MATERIALS AND METHODS
Cell culture and transfection
Canine left ventricular myocytes, isolated from adult dogs, were a kind gift
from Dr. Ira Cohen’s laboratory (Stony Brook University, NY). The primary
cardiac myocytes were plated on 10 mg/ml laminin-coated 35-mm glass
bottom MatTek (Ashland, MA) dishes in KB buffer (K-reversal Tyrode
buffer 35 mmol/L of HEPES, 140 mmol/L of KCl, 8 mmol/L of KHCO3,
2 mmol/L of MgCl2, and 0.4 mmol/L of KH2PO4, pH 7.5). The buffer
was gradually changed to M199 medium supplemented with 15% fetal
bovine serum, 1% streptomycin, and 0.5% gentamicin and incubated at
37C in 5% CO2. Cells were transfected with enhanced green fluorescent
protein (eGFP)-Gb1 and Gg7 vectors (15 mg/106 cells in 60-mm dish) using
calcium phosphate coprecipitation.
Rat neonatal cardiomyocytes were gifts from Dr. Emilia Entcheva (Stony
Brook University). FRTwt and FRTcavþ cells, and the canine GFP-caveo-
lin1 construct were gifts from Dr. Deborah Brown (Stony Brook Univer-
sity). Membrane fractions from FRTwt cells expressing GFP-caveolin1
were prepared as described (16).Binding of eGFP-Cav1 and Alex546-Gaq
using FRET
Harvested FRTcavþGFP cells werewashed twicewith PBS and centrifuged
at 5,000 g for 5min. The cell pellet was resuspended in ripa buffer containing
150 mMNaCl, 0.1%NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10mM
Tris pH8.0, and protease inhibitor cocktail, homogenized and centrifuged at
5,000 g for 5min at 4C.Resulting supernatant was spun at 10,000 g for 1 h at
4C and pellet corresponding to total membrane fraction was collected. The
concentration of total membrane protein was measured with Bradford
protein assay. Purified Gaq protein (19) was labeled with thiol-reactive
Alexa-546 (Invitrogen) and activated using a previously described method
(20). Fo¨rster resonance energy transfer (FRET) measurements between
membranes containing GFP-Cav1 membrane and Alexa546-Gaq were
measured on ISS spectrofluorometer using a similar procedure as previously
described (16). Dilute membrane fractions containing GFP-Cav1 were
placed in a 3 mm2 cuvette and Alexa546-Gaq was incrementally added.
GFP, the FRET donor, was excited at 488 nm and the emission from
the FRETacceptor,Alexa546,wasmeasured from560 to 660 nm.ThedegreeBiophysical Journal 100(7) 1599–1607of FRET was determined from the ratio of Alex546 fluorescence
when exciting donor (488 nm) versus its primary absorption at 546 nm.
The titration was repeated in the presence of 33 mM Cav3-scaf peptide
(Ac-DGIWKASFTTFTVTKYWFYRC).Immunofluorescence
Cardiac myocytes attached to glass bottom imaging dishes were washed
twice with PBS, and fixed with the addition of 3.7% paraformaldehyde
for 30 min. If required, cells were stimulated with carbachol or isoproter-
enol before fixation. For pertussis toxin (PTX) pretreatment, the cells
were starved and incubated with 100 ng/ml PTX overnight. Fixed cells
were washed three times with PBS, and incubated with 0.2% NP40 in
PBS for 5min and then blocked in PBS containing 4% goat serum for
1 h. The cells were incubated with primary antibody Gaq, Gb3, Gai (Santa
Cruz Biochemicals, Santa Cruz, CA) or Cav3 (BD Biosciences, San Jose,
CA) at 1:200 dilution with 1% goat serum in PBS for 1 h. Cells were
then washed three times for 10 min with 150 mM NaCl, 25 mM Tris,
pH 7.6, followed by addition of Alexa-Fluor-488-labeled anti-rabbit or
Alexa-Fluor-647 anti-mouse secondary antibody (Invitrogen, Carlsbad,
CA) diluted to 1:1000 1% goat serum in PBS, and subsequent incubation
at 37C for 1 h and washed three times with TBS. Cells were viewed in
TBS buffer on a laser scanning confocal microscope LSM510-Meta (Carl
Zeiss, Jena, Germany).Confocal imaging and colocalization experiments
Cells were imaged on a laser scanning confocal microscope LSM510
(Carl Zeiss) equipped with multiline laser excitation and a 40/1.2 NA
apochromat water immersion objective. Gb3, Ga, and Gaq were immuno-
labeled with Alexa-488. Alexa-488 fluorophore was excited with 488 nm
and Argon-ion laser line and images were recorded using BP505-530-nm
emission filter. Endogenous Gaq or Cav3 immunolabeled with Alexa-647
were excited with 633-nm line from a He:Ne laser and images were re-
corded using LP650-nm emission filter. The two fluorophores were excited
in a sequential manner using Multi Track acquisition. This procedure
minimizes channel cross talk. Colocalization analysis was performed by
the overlap method using Zeiss AIM software. Threshold values were
determined using the intercellular region of the images.Fluorescence-correlation-spectroscopy
measurements
For a detailed background on fluorescence correlation spectroscopy (FCS),
please see the Supporting Material. Measurements were performed on
a LSM510–Confocor II apparatus (Carl Zeiss) equipped with a 40/1.2
NAwater immersion objective (Apochromat). eGFP was excited with 488-
nm line from the argon ion laser and fluctuations in fluorescence were re-
corded using LP505-nm filter for 10 s 10 times. Alexa546 was excited
with 543-nmHe:Ne laser line and fluctuations in fluorescencewere recorded
using LP560 filter for 10 s 10 times. We calibrated the detection volume by
measuring the diffusion of rhodamine (RhG for 488-nm lasers line and RhB
for 543-nm laser line) in water. This method of calibration using a standard
dye of well-known diffusion coefficient in water, such as rhodamine, is
a common procedure (for method and details see (21)). The calibration is
an estimation of the 1/e2 beam dimension of the excitation laser. The detec-
tion diameter for the 488-nm line was 0.145 0.01 mm and for the 543-nm
line was 0.195 0.01 mm. We used the AIM program from Zeiss to fit the
autocorrelation curves to the model equation for free Brownian diffusion
in two dimensions (22,23) (see the Supporting Material) and calculated
the diffusion coefficient, D from the Einstein relation (see the Supporting
Material). All measurements were performed at room temperature, 25 5
1C, and monitored throughout the experiment using a thermocouple.
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Transfection, culture conditions, and FRET imaging of FRTwt and
FRTcavþ cells were carried out on a Zeiss Concofor II as previously
described (16).Microinjection experiments
Primary cardiomyocytes were cultured in glass bottomMatTek wells for 24
h. Before microinjections, the media was changed to phenol-free Leibovitz-
15 with 14 mM EGTA. The 2 mMCav3-scaf peptide was injected with trace
amounts of DAPI to identify microinjected cells. The control cells were in-
jected with the dye tracer alone. The 2 mM of Gb3 antibody was immuno-
labeled with Alexa546 secondary antibody before microinjecting, as the
injected sample was fluorescent we did not include tracer dye for these
experiments. We used an InjectMan NI2 with a FemtoJet pump from Ep-
pendorf mounted on Axiovert 200 M (Carl Zeiss) equipped with a long
working distance 40 phase 2 objective. Using self-pulled needles, we mi-
croinjected the sample into the cytoplasm. We typically set the injection
pressure Pi ¼ 90 hPa, and kept the compensation pressure Pc ¼ 45 hPa.
The injection time was t¼ 0.7 s. Typically, we injected ~10–25 cells within
a 10- to 20-min period. We examined the microinjected cells under the
phase microscope to select viable cells.Confocal imaging and Calcium sparks
measurements
Ventricular cardiomyocytes were incubated with calcium green AM (5 mM;
Molecular Probes) for 30 min at room temperature and in the dark, washed
two times with Leibovitz15 medium with 14 mM EGTA, and incubated for
another 30 min in Leibovitz15 medium containing14 mM EGTA with or
without 10 mM U73122 PLC inhibitor. Cells loaded with calcium green
were microinjected with peptide and calcium response was measured after
stimulation with 5 mM carbachol or 1 mM isoproterenol. Cells were treated
with 10 mM xestospongin C or ryanodine as described (24,25).
Confocal fluorescence imaging was performed with a confocal scanning
laser microscope system (Fluoview, Olympus, Tokyo, Japan) coupled to an
inverted microscope (IX70, Olympus) with a 40 objective (UPlanApo,
Olympus, numerical aperture 1.3). Calcium green was excited with 488-
nm laser line and images were collected using an LP515 emission filter.
We collected frames at 500-ms intervals. Intensity values for each pixel
were extracted using Olympus software and ImageJ. The line scan mode
was used for quantitative analysis of faster Ca2þ transients and Ca2þ sparks.The pixel size used in this study was 0.1–0.3 mm. Line-scan rate was
1.76 ms per 256-pixel line or 1.3 ms per 512-pixel line.RESULTS
Colocalization between Cav3 and Gbg decreases
with stimulation
We began this study by testing the idea that caveolae may
directly affect intracellular Ca2þ activity by sequestering
Gaq subunits, thereby affecting PLCb activity. For these
studies, we used a primary cell line, left ventricular adult
canine cardiac myocytes, in which Cav3 is the main struc-
tural component of caveolae (26). We first determined the
cellular localization and distribution of Cav3 and Gaq by
immunofluorescence. For comparison, we also studied Gai
and Gb3, which do not bind specifically to Cav1 (17), and
noted that Gb3 is the predominant Gb isoform in adult car-
diomyocytes (27). We found that Cav3 is distributed along
the sarcomers and Z-lines and very little is seen in internal
sites (Fig. 1). In contrast, Gaq, Ga, and Gb are all seen in
internal sites and on the plasma membrane (Fig. 1).
We then measured the amount of colocalization between
Cav3 and the G-protein subunits. It is important to note that
colocalization is essentially determined by the pixel overlap
between one or more fluorescence channels. This measure-
ment will only suggest that the proteins are/are not localized
in the same spatial region of the cell, whose resolution is
governed by the optical and detection system of the micro-
scope. Therefore, in the studies described below, we base
our results on the changes in colocalization of the anti-
body-tagged proteins under the same cellular conditions,
and corroborate colocalization studies with fluorescence
fluctuation methods (described below) that are not reliant
on spatial restrains. A review of the colocalization and its
limitations has been published (28).
We found that Cav3 and G-protein subunits all showed
significant colocalization and actual values varied somewhatFIGURE 1 (A) Coimmunofluorescence studies
showing the colocalization between Cav3 and
Gaq and Cav3 and Gai in the basal and stimulated
states (i.e., after addition of 5 mM carbachol for
Gaq and 1 mM isoproterenol for Gai). (Upper)
Example of cells stained for Gaq (green) and
Cav3 (red) showing normal and expanded overlay
images. (Lower) Compilation of colocalization
data from 3 separate experiments where n ¼ 11–
18. (B) Similar results of coimmunofluorescence
showing the colocalization of Cav3 and Gb3 in
the basal state and stimulated with 5 mM carbachol
where p ¼ < 0.001 (ANOVA) for the basal and
stimulated groups. The PTX-treated group was
stimulated with 5 mM isoproterenol and did not
differ significantly from the basal group.
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differences between the accessibility of the antibodies to
the different epitopdes, the fluorescence properties of the
secondary antibodies, and the strength and specificity of
the antibody used. We also measured changes in colocaliza-
tion of the proteins after stimulationwith 5mMcarbachol and
found that stimulation does not significantly affect the degree
of colocalization betweenCav3 andGaq. Similarly,we found
that stimulation with 5 mM isoproterenol does not affect the
degree of colocalization between Cav3/Gai (Fig. 1 A).
However, carbachol causes a significant overall drop in the
mean value of the colocalization between Cav3/Gb3 (Fig. 1
B). This decrease is diminished when the cells are pretreated
with PTX and stimulated with isoproterenol, which will
prevent activation of Gai and Gao. This result suggests that
Gbg subunits released from activated Gaq and other Ga iso-
types can dissociate from caveolae domains.Stimulation of cardiomyocytes with carbachol
increases mobility of Gbg subunits
The colocalization studies suggest that Gbg can dissociate
from caveolae with carbachol stimulation. We expect that
stimulation should increase the mobility of Gbg as it
becomes released from caveolae. To test this idea, we
measured the change in the diffusion coefficient of Gbg in
live cardiomyocytes in the basal state and 1–15 min after
stimulation. Initially, we carried out these studies by trans-
fecting the cardiomyocytes with eGFP-Gb1g7 and moni-
toring diffusion by FCS (see (29)). Due to the very low
transfection efficiency, we were able to collect reliable
data for only a few cells (n¼ 7). We found that the diffusion
coefficients of eGFP-Gb1 in these cells are too slow to be
measured. This limited mobility is expected if Gb1 is local-
ized in large protein domains, such as caveolae. However,
the addition of carbachol resulted in an increase in the
diffusion constant in all but two of the cells to a value of
D ¼ 0.6 5 0.1 mm2/s, n ¼ 5. The value of this diffusion
constant corresponds to a monomeric or a small oligomeric
membrane associated protein (i.e., http://www.sbcny.org/
membrane_diffusion_coefficients.htm) and shows that
carbachol stimulation increases Gbg mobility.
To support the studies described above, we measured the
diffusion coefficient of purified Gb1g2 that was covalently
labeled with Alexa546 and microinjected into the cardio-
myoctyes. Although the diffusion of the microinjected
protein was very rapid in some cells suggesting an inappro-
priate localization, in other cells the microinjected protein
had a very limited mobility similar to the transfected
protein, suggesting localization in large protein domains.
Stimulation of the latter cells with carbachol resulted in
increased mobility of Alexa546-Gb1g2 to a value compa-
rable to eGFP-Gb1g2 transfected under stimulated condi-
tions (D ¼ 0.6 5 0.1 mm2/s, n ¼ 6). Taken together, the
very limited mobility of Gbg in the basal state, followedBiophysical Journal 100(7) 1599–1607by a more rapid diffusion after treatment with carbachol,
is consistent with release of a population of Gbg from cav-
eolae domains with Gaq activation.Gaq interacts with Cav3 through the scaffold
domain
Stabilization of the activated state of Gaq by caveolae,
coupled with the release of Gbg subunits from caveolae
domains upon stimulation, would prolong the activation
of PLCb enzymes and increase the duration of Ca2þ
events. We tested the idea that Cav3 is playing an active
role in Ca2þ signaling by determining the changes in
Ca2þ activity when interactions between Cav3 and Gaq
are disrupted. For these studies, we first developed a reagent
that would interfere with the binding of Cav3 and Gaq.
Activated Gaq has been suggested to bind to the scaffold
region of Cav1 (30), which has high homology to the scaf-
fold domain of Cav3. We synthesized a peptide corre-
sponding to this sequence (Cav3-scaf). We first tested the
ability of Cav3-scaf to interfere with the association
between activated Gaq and caveolae. For these studies,
we prepared membrane fractions from FRT cells trans-
fected with GFP-Cav1 (these cells do not endogenously
express caveolae, but will express and localize GFP-Cav1
appropriately and have been used as models for caveolae
studies, see (16,30)).
We measured the association of Alexa546-Gaq to GFP-
Cav1 by FRET. FRET will occur when excited energy
from a donor molecule (i.e., GFP) is transferred to an
acceptor (i.e., Alexa546) when the probes are within ~50 A˚
(see (31)). This method allows one to view associations
between two soluble or membrane-associated proteins in
real time (see (32,33)). The association between the
Alexa546-Gaq and GFP-Cav1 is observed by the increase
in Alexa546 emission when exciting GFP due to transfer
from this donor as compared to its intensity when only
Alexa546 is excited.
We tested the ability of the Cav3-scaf peptide to disrupt
the association of Gaq to Cav1. We found that Cav3-scaf
significantly lowers their association (Fig. 2) due to compe-
tition of Cav1 for Gaq. Because the scaffold regions of Cav1
and Cav3 are very homologous but not identical, we expect
Cav3-scaf to be a slightly more effective competitor for
Gaq–Cav3 association. We then determined whether
Cav3-scaf could disrupt the association between Gaq and
Cav3 in cardiomyoctyes by microinjecting the peptide into
cells and measured its effect on Cav3/Gaq colocalization.
We tracked cells that were microinjected by including
trace amounts of DAPI in the microinjection solution, which
stains the nucleus. We found that the Cav3-scaf peptide
significantly reduces the colocalization between Cav3
and Gaq (Fig. 3). Control studies show that Cav3-scaf
does not disrupt the association between Gaq and Gbg
subunits.
FIGURE 2 Decrease in the association of Alexa546-Gaq(GTPgS) and
GFP-Cav1 dispersed in FRT membranes in the absence (C) and presence
(B) of Cav3-scaf peptide. In this study, binding was monitored by the
increase in FRET, as determined by comparing the fluorescence emission
intensity (F.I.) at 580 nm of Alexa546 acceptors exciting only at 546 nm,
to the increase in Alexa546 fluorescence emission intensity at 580 nm
when exciting GFP donors at 488 nm. The increase in F.I. at l(em) ¼
580 nm is due to FRET from the GFP donors (at l(ex) ¼ 488 nm) to
Alexa546 (at l(ex) ¼ 546).
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state of Gaq
The above studies, along with previous work (16,17) imply
that Cav3 stabilizes the activated state of Gaq through
specific binding interactions. To support this idea, we
carried out a series of studies using the C2 domain of
PLCb1 as a tool to monitor activated Gaq. It has been shown
that C2 domain of PLCb1 binds strongly and specifically to
activated Gaq (34). Because this C2 domain does not bind to
membranes (34), activation of Gaq should then promote its
movement from the cytosol to the plasma membrane.
We expressed PLCb1-C2 in bacteria, labeled the purified
protein with Alexa546, and microinjected the solution intocardiomyocytes. We expected the probe to be primarily
cytosolic, but we found that it forms small aggregates
throughout cardiomyocytes making changes in localization
difficult to assess by fluorescence imaging. Thus, we carried
out our studies using FRT cells because we found that in
these cells microinjected Alexa546-C2 is freely diffusing
and primarily localized in the cytosol, although small
amounts are found on the plasma membrane.
We then compared the behavior of Alexa546-C2 microin-
jected into FRT cells (FRTwt), which do not contain caveo-
lae, to its behavior in a stable Cav1 transfected line that
displays caveolae domains (FRTcavþ) (see (30)). Addition-
ally, both cell types were transfected with eGFP-Gaq.
FRETwas then used to determine changes in the association
between Alexa546-C2 and eGFP-Gaq. Measurements were
taken within 3 min after stimulation where sustained Ca2þ
levels in FRTcavþ but not FRTwt cells are observed (16).
In the basal state, we found that the amount of FRET is
higher in FRTwt versus FRTcavþ cells (5.3 5 1.0%, n ¼
13 versus 2.45 0.9%, n¼ 8 where the values were obtained
by comparing the background-corrected FRET to a positive
control, eGFP-PHPLCd1-Alexa546 and a negative control,
free eGFP and free Alexa546, see (35)) suggesting that in
the absence of caveolae, more Gaq is available for C2
binding. Both cell types show a similar increase in FRET
(11.05 2.5%) with stimulation. Three minutes after stimu-
lation, only 16% of the FRTcavþ cells returned to basal level
FRET values, whereas 50% of the FRTwt cells returned to
basal levels suggesting that the presence of caveolae helps
sustain the activated state of Gaq.
To support the FRET studies, we determined the change in
the diffusion of Alexa546-C2 microinjected into FRTwt and
FRTcavþ cells using FCS. In both FRTwt and FRTcavþ cells,
we observed a fast diffusion component that can be correlated
with the cytosolic population, and a slower moving popula-
tion that we interpret to represent the fraction of C2 that isFIGURE 3 Decrease in the colocalization
between Gaq and Cav3 in the presence of Cav3-
scaf peptide. Here, colocalization was determined
by selecting the plasma membrane region rather
than the whole cell to yield higher initial values.
An identical study showing the lack of change
between Gbg and Cav3 is shown for comparison.
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prebound fraction is significantly higher than in FRTcavþ
cells (0.16 5 0.03, n ¼ 5, versus 0.10 5 0.01, n ¼ 14)
even though the values of their mobility were the samewithin
error (D¼ 2.55 0.1mm2/s andD¼ 2.45 0.2mm2/s, respec-
tively). The higher amount of prebound material in the
caveolae-free cells agrees with the basal state FRET values
measured in these cells.
Stimulation of the cells results in distinct effects on the
mobility of Alexa546-C2. The fraction of the slow moving
population in FRTwt cells significantly decreased from
0.165 0.03 to 0.115 0.02 (p< 0.03) and the corresponding
change inmobility was modest (after stimulation, D¼ 1.85
0.2 mm2/s). In FRTcavþ cells, we observed a small but not
significant increase in the fraction of slow population
(from 0.10 5 0.01 to 0.13 5 0.02) and a small but not
significant decrease in mobility from D ¼ 2.45 0.2 mm2/s
to 2.0 5 0.2 mm2/s (n ¼ 13). We interpret the FCS results
shown in Fig. 4 as follows: the decrease in the fraction of
slow moving population in the caveolae-free cells, with
a concomitant increase in association as seen by FRET, is in-
terpreted as detachment of Gaq from the receptor molecules
as they cluster and internalize into endosomes. Alternately,
in caveolae-containing cells, our data show that an increased
amount of Alexa546-C2 bound to a slower moving popula-
tion of activated Gaq. Coupled with the colocalization
studies, these results suggest that caveolae stabilizes the acti-
vated form of Gaq.
To strengthen the argument that caveolae stabilize Gaq,
we microinjected Cav3-scaf and Alexa546-C2 intoFIGURE 4 Gaq activation, as reported by the mobility of Alexa546-C2
domain, depends on the presence of caveolae. (A) Treatment with 5 mM
carbachol significantly decreases the fraction of slowly diffusing particles
in FRTwt (hatched), p < 0.03, and does not produce significant changes
in FRTcav (solid) cells. (B) The diffusion coefficient of Alexa546-C2 in
both cell types is not significantly affected by the carbachol treatment.
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We found that the value of FRET from eGFP-Gaq to
Alexa546-C2 returns to basal levels 3 min after stimulation
(5.3 5 1.0%, n ¼ 13 (basal), 5.1 5 0.8%, n ¼ 5 (30 after
stimulation) suggesting that sustained Gaq activation does
not occur in the presence of peptide. Additionally, change
in the slow moving fraction in the stimulated state followed
the change observed for FRTwt cells (from 0.16 5 0.02
before stimulation to 13 5 0.02 after stimulation; n ¼ 6).
These results are consistent with the ability of the peptide
to compete for Gaq-caveolae interactions, and support the
idea that activated Gaq localizes in caveolae domains where
its activated state can be prolonged.Caveolae impacts Ca2D activity in
cardiomyocytes
We determined whether the interaction between Gaq
and caveolae affects Ca2þ signals in live cardiomyocytes.
To isolate Ca2þ release from internal stores through the
Gaq-PLCb mediated pathway, as opposed to extracellular
Ca2þ entry, we carried out these studies in Ca2þ-free
medium. Intracellular Ca2þ levels were monitored using
a fluorescent Ca2þ indicator (Ca2þgreen). We carried out
our studies in adult canine ventricular cardiac myocytes
that were cultured for 2 days, which allowed firm adhesion
of the cells on the substrate as required for microinjection
studies (see below). We note that similar behavior was
observed using freshly isolated atrial myocytes and no
significant differences in the Ca2þ activity between the fresh
and cultured ventricular cardiomyocytes were observed.
In the absence of extracellular Ca2þ, we observed waves
with peakwidths of ~20 s after the addition of 5 mMcarbachol
(Fig. 5 A, upper trace). These same traces were seen when
identical frames were rescanned over 20–100 times at 500-ms
intervals. Embedded in these waves were at least two sets or
more of many narrow waves having widths in the second and
microsecond range. Due to the lack of extracellular Ca2þ,
these shorter Ca2þ spikes somewhat mask the longer waves
caused by release of Ca2þ from internal stores (i.e., puffs).
Control studies that measured free dye and electronic noise
showed that the very fast events occurring in the millisecond
time scalewere intensityfluctuations caused by free dyemole-
cules diffusing through the field of view, whereas the slower
oscillating was due to intracellular Ca2þ fluctuations.
We analyzed our data using intensity binning. In this
method, the intensity values of a certain magnitude are
placed in a particular bin depending on its value. By keeping
the time scale of the experiment constant, we can determine
the relative number of intensities of a particular value. Thus,
narrow or short duration time events would give many
similar intensity values and the resulting histograms would
be very narrow, but longer waves that give intensities over
a longer time period will give a much broader histogram.
Binning allows us to group over 500 traces of scans of
FIGURE 6 (Upper panels) Compilation of 25 sets of histograms that
were binned into nine sets for control cells (right) and Cav3-scaff microin-
jected cells (left) showing the differences in bin population and distribution.
(Lower) Summary of bin analysis of the Ca2þ activity in canine adult
ventricular cardiomyocytes data (see text). Note that myocytes microin-
jected with Cav3-scaf peptide (C) or treated with the PLC inhibitor
U73132 (D) had the largest population of intensities in the shorter time
bins reflecting the elimination of the Ca2þ slow waves (i.e., Ca2þ puffs).
In contrast, untreated cells (;), cells microinjected with control peptide
(-) or cells treated with ryanodine (B) showed bin populations at a longer
time reflecting the presence of slow waves.
FIGURE 5 (A, Upper trace) Ca2þ activity, as measured by Ca2þ Green
intensity, in adult canine ventricular myocytes as a function of time in
seconds after the addition of 5 mM carbachol. Raw data is seen as the noisier
trace and an average of three traces is the smooth overlaid curve. (Lower
trace) Decrease in the Ca2þ activity in canine ventricular myocytes that
were microinjected with Cav3-scaff as a function of time in seconds after
the addition of 5 mM carbachol. Raw data is seen as the noisier trace and
an average of three traces is shown is the smooth overlaid curve (B) Corre-
sponding histogram analysis of the control cells and Cav3-scaf microin-
jected cells (C) set binned at 35.
Caveolae Regulates Ca2þ via Ga 1605different cells and regions, along with rescans of the same
image, and visualize the compiled results spatially and
temporally on a single plot. Thus, the slow Ca2þ waves
that may be difficult to discern when the scans are overlaid
due to different peak placement and noise can be readily
seen in the binned histograms. Binning the data in Fig. 5 B
results in a broad skewed Gaussian histogram correspond-
ing to intensities that are spread over a large time range.
We note that the shape on this plot will not depend on the
number of bins but will depend on the time scale of the
scans.
We then compared the Ca2þ behavior of cells that were
microinjected with the Cav3-scaf peptide. Injection of this
peptide should disrupt Cav3-Gaq association and we found
that the Cav3-scaf peptide drastically reduced the magni-
tude of the slow waves (Fig. 5 A, lower trace) causing the
shape of the histogram graph to become very narrow as
compared to the control (Fig. 5 C).
To better compare these experiments, we averaged 20–25
sets of experimental data and generated histograms by
binning into nine segments (all of the above data were arbi-
trarily but consistently binned at 35). This smaller bin count
allowed all the short spikes to be grouped into the first few
bins. In Fig. 6 (upper panels) we show the population of
species in each bin. As can be seen, cells that were microin-
jected with the Cav3-scaf peptide had a considerably higher
population of intensities in the shortest time bracket reflect-
ing the elimination of slow waves.We carried out several control studies to support the idea
that Cav3-Gaq interactions are contributing to Ca
2þ activity.
We first substitutedCav3-scaf for a control peptide having the
same length and charge. Although microinjection of this
peptide reduced the magnitude of the Ca2þ signal, it did not
affect the properties of the waves (Fig. 6, lower) supporting
the idea that the effect of Cav3-scaf on Ca2þ activity is
specific. Treatment of the cells with the PLC inhibitor
U73132 eliminates the slowerCa2þwaves (Fig. 6, lower) sup-
porting the idea that these waves are generated through the
Gaq–PLCb–IP3 pathway. Treatment of the cells with 1 mM
ryanodine, which will completely block RyRs, did not affect
the Ca2þ activity as expected becausewe are carrying out our
studies in Ca2þ-freemedia. As a final control, we repeated the
studies in fresh, neonatal cardiomyocytes from rat. Rat
neonatal cardiomyocytes do not express Cav3 and do not
contain caveolae (36). When viewed at short times, we found
that only very fast Ca2þ activity is seen and the baseline,
which has structure in adult cells due to slow waves, is
completely flat showing the absence slow Ca2þ activity (see
the Supporting Materials) when Cav3 is not expressed.DISCUSSION
In this study, we present evidence showing that caveolae
regulate slow Ca2þ waves in adult cardiomyocytes throughBiophysical Journal 100(7) 1599–1607
1606 Guo et al.specific interaction with Gaq and linking this pathway to
cardiomyopathy in Cav3 null mice (18). Caveloae are
perhaps the most well-characterized plasma membrane
protein domains and are implicated to play passive roles in
many cellular processes (see (10–13)). Interestingly, caveo-
lae are found in many, but not all, mammalian cells implying
that they may play a role more in modulating rather than
directing cell function. Studies using methods such as cell
fractionation and immunofluorescence have suggested that
caveolae localizes related proteins into organized domains
to allow rapid signaling. In adult cardiomyocytes,many types
of G-protein coupled receptors and their corresponding
G-proteins have been shown to localize in caveolae domains
(38). However, the idea that caveolae can directly affect
G-protein signals have only recently been implied from
studies using transfected cultured cells (16). In cells that do
not contain caveolae, Gaq and Gbg are complexed in the
basal state and remain associated upon stimulation, but in
caveolae-containing cells, Gaq separates from Gbg with
carbachol stimulation. This separation appears to result
from high affinity interactions between Cav1 and activated
Gaq that may prolong the Ca
2þ response (16,17).
We carried out the majority of our studies in cardiomyo-
cytes. Adult canine cardiac myocytes contain large and
regularly spaced caveolae domains that run along the
Z-lines of actin filaments (38). Previous studies found that
Cav3 is localized on the plasma membrane which we
observe, and also in perinuclear regions (38) which we do
not observe. It is possible that these differences may be
traced to differences in sample preparation. However, the
distributions of G-protein subunits in our study closely
match the pattern reported in the study cited above.
In COS and FRT cells, Gaq has been shown to localize in
caveolae domains (15,16) and the observed loss in colocal-
ization in cells treated with the Cav3-scaf peptide support
a caveolar localization. We also found a high degree of co-
localization between Gbg and Cav3 that decreases with
stimulation. Our FCS measurements show that Gbg
subunits are released from large, immobile domains with
stimulation. These results suggest that Gaq activation allows
movement of Gbg out of caveolae due to the loss in affinity
between the subunits upon activation (19), concomitant with
strong binding between activated Gaq and Cav3.
Using the C2 domain of PLCb1, we obtained evidence
that Gaq remains in caveolae domains after activation where
it remains activated for a longer period than in the absence
of these domains. This behavior can be reversed by the
Cav3-scaf peptide that disrupts caveolin-Gaq interactions.
The ability of caveolae to stabilize activated Gaq shows
that the scaffold domain of Cav3 functions as an inverse
GTPase activating protein (i.e., GAP, e.g. (39,40).), and it
may be expected to compete for RGS proteins.
Cardiomyocytes havedistinct andwell-characterizedCa2þ
signals that take the form of puffs, sparks, waves, etc., de-
pending on the time of the signal and the extent of localizationBiophysical Journal 100(7) 1599–1607in the cell (see (1)). The localizedCa2þ signalswe observe for
adult cardiomyocytes appear as slow oscillating waves. In
adult ventricular cardiomyocytes immersed in Ca2þ-contain-
ingmedia, localized Ca2þ signals can occur through RyR and
Ca2þ-induced Ca2þ channels that originate at transverse
tubules (i.e., Ca2þ sparks). It is notable that atrial and neonatal
cells do not contain transverse tubules and it has been
proposed that caveolae help generateCa2þsparks by coupling
RyR in the SR with Ca2þ channels (41). Because our studies
were carried out in the absence of extracellular Ca2þ, and
because the slow Ca2þ waves we observed are independent
of RyR, we are not viewing Ca2þ sparks. Rather, our Ca2þ
activity falls into the category of puffs, which are signals initi-
ated by IP3 receptors. IP3 is generated by PLC-catalyzed
hydrolysis of PIP2, which is stimulated by Gaq activation
(see (9)). We find that stimulation of the cells in the absence
or presence of extracellular Ca2þ only affects thewidth of the
narrow spikes rather than the slowwaves, which is consistent
with sparks. In accordance with previous reports, Ca2þ puffs
have a pacemaker quality and appear in excitable and nonex-
citable cell types (i.e., (41)). Although their amplitude and
frequency is cell type-dependent, the basic characteristics
of puffs do not differ significantly between cell types consis-
tent with puffs being a basic element of Ca2þ signaling. In
HeLa cells, the activity of puff sites will determine whether
a global Ca2þwave or an abortive response is generated (41).
Our localization and diffusion studies show that caveolae
influence the time scale of activation and movement of
G-proteins with stimulation, whereas our functional studies
suggest that the pacemaker-like Ca2þ puffs are under caveo-
lae control. Histogram analysis of Ca2þ activity show that
these slower waves are not observed in neonatal cells that
do not contain Cav3 (36), when PLC is inhibited or when
Gaq-Cav3 association is disrupted by the Cav3-scaf peptide.
It is possible that cardiomyocytes have a basal oscillating
Gaq signal that is dependent on caveolae through specific
binding of Cav3 to Gaq. Release of Gbg from caveolae
domains will remove it from caveolae-localized effectors
but promote its association to effectors outside caveolae
domains, such as adenylyl cyclase, that may result in sus-
tained signals from Gbg associated pathways.
Taken together, these studies present strong evidence that
caveolae can modulate cell signals. Although other more
indirect mechanisms are possible, direct interaction between
Cav3 and Gaq, which in turn affect the PLC activity and
Ca2þ signals, is the simplest explanation that fits all of our
data. Our results offer the possibility that different caveolae
domains affect different signaling pathways. Of importance,
our studies show that certain cell signals may be manipu-
lated through reagents targeted to caveolin proteins.SUPPORTING MATERIAL
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